AbbVie advertising spend, FY2025
AbbVie (ABBV) reported $2.1B of advertising expense for the fiscal year ended Dec 31, 2025. That is 3.4% of revenue of $61.2B. Up 0.0% from FY2024.
Key facts
- Ad spend is 3.0x its FY2015 level ($704M), faster than revenue (2.7x).
- The highest year on file is FY2023 at $2.2B; FY2025 is 5% below it.
- Largest increase +63.6% in FY2020; largest cut -4.8% in FY2022.
- Ad spend is 3.4% of revenue, down from 3.9% in FY2020.
- AbbVie spends more on advertising than 93% of the 458 US-listed companies tracked. Its ad-to-revenue ratio is below the median of 4.5%.
Ad spend by fiscal year
Ad spend as % of revenue
Ad spend in context, FY2025
Advertising was 15.0% of selling, general and administrative expense. Research and development spending was 4.3x advertising. Advertising equalled 13.9% of operating income.
| Advertising | $2.1B | AdvertisingExpense |
|---|---|---|
| Selling, general and administrative | $14B | ad spend = 15.0% |
| Research and development | $9.1B | R&D = 4.3x ad spend |
| Operating income | $15.1B | ad spend = 13.9% |
| Net income | $4.2B |
Same fiscal year and filing as the ad spend. Selling and marketing and SG&A usually include advertising.
History
Download CSV| Fiscal year | Period end | Ad spend | YoY | Revenue | Ad / revenue | Tag | Filing |
|---|---|---|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.1B | 0.0% | $61.2B | 3.4% | AdvertisingExpense | 10-K Feb 20, 2026 |
| FY2024 | Dec 31, 2024 | $2.1B | -4.5% | $56.3B | 3.7% | AdvertisingExpense | 10-K Feb 20, 2026 |
| FY2023 | Dec 31, 2023 | $2.2B | +10.0% | $54.3B | 4.1% | AdvertisingExpense | 10-K Feb 20, 2026 |
| FY2022 | Dec 31, 2022 | $2B | -4.8% | $58.1B | 3.4% | AdvertisingExpense | 10-K Feb 14, 2025 |
| FY2021 | Dec 31, 2021 | $2.1B | +16.7% | $56.2B | 3.7% | AdvertisingExpense | 10-K Feb 20, 2024 |
| FY2020 | Dec 31, 2020 | $1.8B | +63.6% | $45.8B | 3.9% | AdvertisingExpense | 10-K Feb 17, 2023 |
| FY2019 | Dec 31, 2019 | $1.1B | 0.0% | $33.3B | 3.3% | AdvertisingExpense | 10-K Feb 18, 2022 |
| FY2018 | Dec 31, 2018 | $1.1B | +30.0% | $32.8B | 3.4% | AdvertisingExpense | 10-K Feb 19, 2021 |
| FY2017 | Dec 31, 2017 | $846M | +10.7% | $28.2B | 3.0% | AdvertisingExpense | 10-K Feb 21, 2020 |
| FY2016 | Dec 31, 2016 | $764M | +8.5% | $25.6B | 3.0% | AdvertisingExpense | 10-K Feb 27, 2019 |
| FY2015 | Dec 31, 2015 | $704M | +5.9% | $22.9B | 3.1% | AdvertisingExpense | 10-K Feb 16, 2018 |
| FY2014 | Dec 31, 2014 | $665M | +6.2% | $20B | 3.3% | AdvertisingExpense | 10-K Feb 17, 2017 |
| FY2013 | Dec 31, 2013 | $626M | +23.7% | $18.8B | 3.3% | AdvertisingExpense | 10-K Feb 19, 2016 |
| FY2012 | Dec 31, 2012 | $506M | +34.9% | $18.4B | 2.8% | AdvertisingExpense | 10-K Feb 20, 2015 |
| FY2011 | Dec 31, 2011 | $375M | n/a | $17.4B | 2.1% | AdvertisingExpense | 10-K Feb 21, 2014 |
Ad spend, revenue and the ratio come from the linked filing. YoY compares each year with the fiscal year directly before it, under the same tag. A gap, a change of tag or a change of fiscal year end leaves it blank.
What the figure is
Advertising costs as disclosed in the annual report (XBRL tag AdvertisingExpense).
Compared with similar spenders
The 6 companies closest to AbbVie in latest-year ad spend.
Questions
How much does AbbVie spend on advertising?
AbbVie spent $2.1B on advertising in fiscal 2025, the year ended Dec 31, 2025, according to its 10-K filed Feb 20, 2026.
What percentage of revenue does AbbVie spend on advertising?
3.4% of revenue in fiscal 2025 ($2.1B against $61.2B). The median across the 458 companies tracked is 4.5%.
Is AbbVie spending more on advertising?
Yes. Ad spend rose 0.0% in fiscal 2025 from fiscal 2024.
How does AbbVie rank by advertising spend?
#33 of 458 US-listed companies with $50M or more in ad spend, ranked on each company's latest fiscal year.
Does AbbVie spend more on advertising than on R&D?
No. In fiscal 2025 it spent $9.1B on research and development and $2.1B on advertising.
What does AbbVie's advertising figure include?
Advertising costs as disclosed in the annual report (XBRL tag AdvertisingExpense).
Company and source
- Filing
- 10-K for FY2025, filed Feb 20, 2026
- Accession number
0001551152-26-000008- Company
- AbbVie Inc., CIK 1551152, SIC 2834 (Pharmaceutical Preparations)
- Headquarters
- North Chicago, IL
- Incorporated in
- DE
- Fiscal year ends
- December 31
- Listed on
- NYSE
- SEC filer status
- Large accelerated filer
- Data
- SEC EDGAR XBRL company facts, retrieved Nov 18, 2026. Methodology.
- Cite
- AbbVie advertising spend, FY2011-FY2025. Aleksei Trudov, io.trudov.com, from SEC EDGAR XBRL company facts (latest: 10-K filed Feb 20, 2026), retrieved Nov 18, 2026. https://io.trudov.com/company/abbvie/advertising-spend/
- Download
- CSV, all years · CSV, all 458 companies